Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in HALOZYME THERAPEUTICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 528,031 shares of HALO (HALOZYME THERAPEUTICS INC), worth $34.1M as of 2026-Q1. The position was decreased (-28.0% shares). HALO represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$34.1M
Current Shares
528,031
Total Value Change
+$11.5M
Total Shares Change
+96,007
Other major holders of HALO: BNP PARIBAS FINANCIAL MARKETS
Decreased |
| 528,031 |
-28.0% |
| $34.1M |
| 0.0% |
| $69.40 |
0 |
| 2025-Q4 | Increased | 733,562 | +124.3% | $49.4M | 0.0% | $67.70 | 47 |
| 2025-Q3 | Decreased | 326,967 | -34.1% | $24M | 0.0% | $73.29 | 0 |
| 2025-Q2 | Increased | 496,344 | +19.2% | $25.8M | 0.0% | $52.21 | 34 |
| 2025-Q1 | Increased | 416,262 | +6.8% | $26.6M | 0.0% | $63.84 | 31 |
| 2024-Q4 | Decreased | 389,875 | -2.0% | $18.6M | 0.0% | $47.99 | 0 |
| 2024-Q3 | Decreased | 397,833 | -7.9% | $22.8M | 0.0% | $56.97 | 0 |
| 2024-Q2 | Increased | 432,024 | +168.4% | $22.6M | 0.0% | $52.36 | 46 |